GYSN Stock Overview
Greyson International, Inc. engages in the research, development, manufacture, distribution, and marketing of beauty and pharmaceutical products.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Greyson International, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -98.77% |
5 Year Change | -92.86% |
Change since IPO | -99.98% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
GYSN | US Personal Products | US Market | |
---|---|---|---|
7D | 0% | 4.1% | 1.2% |
1Y | n/a | -26.0% | 24.9% |
Return vs Industry: Insufficient data to determine how GYSN performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how GYSN performed against the US Market.
Price Volatility
GYSN volatility | |
---|---|
GYSN Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 8.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GYSN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GYSN's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | n/a | n/a | www.greysonproducts.com |
Greyson International, Inc. engages in the research, development, manufacture, distribution, and marketing of beauty and pharmaceutical products. It offers Trilexon, a skin care delivery system. The company also provides anti-aging skin care products, such as foaming cleansers, pore diminishing toners, moisturizers, night creams, and eye creams under the Trilexon brand name.
Greyson International, Inc. Fundamentals Summary
GYSN fundamental statistics | |
---|---|
Market cap | US$15.53k |
Earnings (TTM) | -US$864.96k |
Revenue (TTM) | US$40.24k |
0.0x
P/S Ratio0.0x
P/E RatioIs GYSN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GYSN income statement (TTM) | |
---|---|
Revenue | US$40.24k |
Cost of Revenue | US$8.40k |
Gross Profit | US$31.83k |
Other Expenses | US$896.79k |
Earnings | -US$864.96k |
Last Reported Earnings
Mar 31, 2012
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did GYSN perform over the long term?
See historical performance and comparison